Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Melatonin may help treat PCOS symptoms in rats.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Women with PCOS may be more likely to have gum disease than healthy women.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Neurosteroids show promise for treating epilepsy and more research is needed.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Finasteride effectively treats baldness but may cause sexual side effects.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.